Evidence map›Paper›PMID 28081715›Full record

ArticleGenome medicine2017

Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.

Georgina L Ryland, Sally M Hunter, Maria A Doyle, Franco Caramia, Jason Li, Simone M Rowley, Michael Christie, Prue E Allan, Andrew N Stephens, David D L Bowtell and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Therapeutic Cancer Vaccines for Nonmelanoma Skin Cancer.Current treatment options in oncology · 2023
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Georgina L RylandCancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Sally M HunterCancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Maria A DoyleBioinformatics Core Facility, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Franco CaramiaBioinformatics Core Facility, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Jason LiBioinformatics Core Facility, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Simone M RowleyCancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Michael ChristieDepartment of Anatomical Pathology, Royal Melbourne Hospital, Parkville, VIC, Australia.
Prue E AllanDepartment of Pathology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Andrew N StephensCentre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.
David D L BowtellCancer Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Australian Ovarian Cancer Study Group
Ian G CampbellCancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Kylie L GorringeCancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. kylie.gorringe@petermac.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28081715
PMCPMC5228100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.